1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 3:P values for the comparison of tumor grade with respect to rCBV and Ktrans
Tumor Grade P Value rCBV Ktrans (second) I versus II* <.0001 0.4662 I versus III* <.0001 0.0912 II versus III* .0005 0.4424 I versus II and III† <.0001 0.027 I and II versus III† <.0001 0.068
Note.—Grade I = low-grade glioma, grade II = anaplastic astrocytoma, and grade III = GBM.
* Tukey honestly significant difference procedure.
† Unequal variance t test.